RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Rockville, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Regenerx Biopharmaceuticals?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Regenerx Biopharmaceuticals market cap is $300.00.
What is the 52-week high for Regenerx Biopharmaceuticals?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regenerx Biopharmaceuticals 52 week high is $0.121 as of September 13, 2025.
What is the 52-week low for Regenerx Biopharmaceuticals?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Regenerx Biopharmaceuticals 52 week low is $0.0002 as of September 13, 2025.
What is Regenerx Biopharmaceuticals stock price today?
Regenerx Biopharmaceuticals stock price today is $0.0002.
What was Regenerx Biopharmaceuticals stock price yesterday?
Regenerx Biopharmaceuticals stock price yesterday was $0.0002.
What is the 50-day moving average of Regenerx Biopharmaceuticals?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Regenerx Biopharmaceuticals 50-day moving average is $0.0198.